Live Breaking News & Updates on Paris Transplant Group At Inserm

Share this article
Share this article
SOUTH PLAINFIELD, N.J., Jan. 7, 2021 /PRNewswire/ Leading global genomics service provider, GENEWIZ, a Brooks Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft rejection.
The success or failure of organ transplantation largely depends on rejection responses. Rejection accounts for most allograft failures worldwide, with immediate effects on patient mortality, morbidity –  presenting various complications for the patient health – and high societal costs. For nearly 30 years, the Banff Classification of Allograft Pathology has provided ....

United States , France General , United Kingdom , Lindsay Kendall Zuill , Blaise Robin , Alexandre Loupy , French National Medical Research Agency , Paris Transplant Group , Paris Transplant Group At Inserm , Genomics Services , Company Life Sciences , Expertise Center , Brooks Life Sciences Company , Necker Hospital , Spatial Profiler , Nanostring Technologies , Banff Classification , Allograft Pathology , Banff Kidney Meeting , Ginger Zhou , Vice President , Life Sciences , Brooks Life Science , North America , South Plainfield , French National Medical Research ,